187 related articles for article (PubMed ID: 12806951)
21. Hypercalcemia of malignancy.
Body JJ
Semin Nephrol; 2004 Jan; 24(1):48-54. PubMed ID: 14730509
[TBL] [Abstract][Full Text] [Related]
22. A case of resistant hypercalcemia of malignancy with a proposed treatment algorithm.
McMahan J; Linneman T
Ann Pharmacother; 2009 Sep; 43(9):1532-8. PubMed ID: 19622757
[TBL] [Abstract][Full Text] [Related]
23. [How to treat tumor-induced hypercalcemia].
Body JJ
Rev Prat; 2003 Dec; 53(19):2128-35. PubMed ID: 15008469
[TBL] [Abstract][Full Text] [Related]
24. Aminohydroxypropylidene bisphosphonate (APD) treatment for tumor-associated hypercalcemia: a randomized comparison between a 3-day treatment and single 24-hour infusions.
Body JJ; Magritte A; Seraj F; Sculier JP; Borkowski A
J Bone Miner Res; 1989 Dec; 4(6):923-8. PubMed ID: 2692407
[TBL] [Abstract][Full Text] [Related]
25. Use of bisphosphonates for hypercalcemia in a child with alveolar rhabdomyosarcoma.
Corapçioğlu F; Mutlu H; Deveci M
Turk J Pediatr; 2008; 50(3):305. PubMed ID: 18773683
[No Abstract] [Full Text] [Related]
26. Bisphosphonate-associated osteonecrosis: a clinician's reference to patient management.
Grewal VS; Fayans EP
Todays FDA; 2008 Aug; 20(8):38-41, 43-6. PubMed ID: 18767452
[TBL] [Abstract][Full Text] [Related]
27. [Hypercalcemia in malignant diseases. Physiopathology and treatment].
Aasarød K; Lamvik J
Tidsskr Nor Laegeforen; 1989 Apr; 109(12):1293-6. PubMed ID: 2734758
[TBL] [Abstract][Full Text] [Related]
28. [Bisphosphonates in malignant hypercalcemia and bone pain].
Lamy O
Rev Med Suisse Romande; 2004 Feb; 124(2):111-4. PubMed ID: 15095627
[TBL] [Abstract][Full Text] [Related]
29. [Bisphosphonates. A neu therapy principle in calcium and bone metabolism disorders].
Raue F
Internist (Berl); 1999 Apr; 40(4):448-55. PubMed ID: 10354947
[No Abstract] [Full Text] [Related]
30. [Therapy of tumor associated hypercalcemia].
Urologe A; 2004 Sep; 43(9):1185-6. PubMed ID: 15487037
[No Abstract] [Full Text] [Related]
31. [Update on paraneoplastic hypercalcemia. Our experience in the treatment of hypercalcemic states of patients with advanced breast carcinoma].
Grottolo A; Ferrari V; Lazzari R; Mariano MR; Zambruni A; Zaniboni A
Minerva Med; 1988 Jul; 79(7):527-31. PubMed ID: 3405454
[TBL] [Abstract][Full Text] [Related]
32. Medical treatment of malignancy-associated hypercalcemia.
Lumachi F; Brunello A; Roma A; Basso U
Curr Med Chem; 2008; 15(4):415-21. PubMed ID: 18288996
[TBL] [Abstract][Full Text] [Related]
33. Treatment of acute lymphoblastic leukemia-induced extreme hypercalcemia with pamidronate and calcitonin.
Mathur M; Sykes JA; Saxena VR; Rao SP; Goldman GM
Pediatr Crit Care Med; 2003 Apr; 4(2):252-5. PubMed ID: 12749663
[TBL] [Abstract][Full Text] [Related]
34. [Development of bisphosphonates].
Nakatsuka K
Nihon Rinsho; 2003 Feb; 61(2):219-25. PubMed ID: 12638211
[TBL] [Abstract][Full Text] [Related]
35. [Clinical aspects of calcium metabolism disorders of the bone. III. Current topics. 2. Hypercalcemia associated with malignant tumor: progress in the treatment].
Sato K
Nihon Naika Gakkai Zasshi; 1993 Dec; 82(12):2023-7. PubMed ID: 8294802
[No Abstract] [Full Text] [Related]
36. Safety of pamidronate in patients with renal failure and hypercalcemia.
Machado CE; Flombaum CD
Clin Nephrol; 1996 Mar; 45(3):175-9. PubMed ID: 8706358
[TBL] [Abstract][Full Text] [Related]
37. The use of zoledronic acid, a novel, highly potent bisphosphonate, for the treatment of hypercalcemia of malignancy.
Major P
Oncologist; 2002; 7(6):481-91. PubMed ID: 12490736
[TBL] [Abstract][Full Text] [Related]
38. Current management strategies for hypercalcemia.
Pecherstorfer M; Brenner K; Zojer N
Treat Endocrinol; 2003; 2(4):273-92. PubMed ID: 15966562
[TBL] [Abstract][Full Text] [Related]
39. Therapeutical approach of hypercalcemia in malignancy.
Duprez D; Rottiers R; Vermeulen A
Acta Clin Belg; 1983; 38(3):165-70. PubMed ID: 6225289
[No Abstract] [Full Text] [Related]
40. [Neoplastic hypercalcemia with renal insufficiency: treatment with dichloromethylene diphosphonate].
Conte N; Di Virgilio R; Roiter I; Foscolo G; Baruffi C
Clin Ter; 1985 Nov; 115(3):177-80. PubMed ID: 2935356
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
